spacer
home > ebr > Winter 2009
PUBLICATIONS

European Biopharmaceutical Review

ebr
Winter 2009
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EBR provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of of biopharmaceuticals, take a look below at the range of articles featured in this issue of EBR
   
Text
PDF
bullet
BioFinance and Management
Independent consultant Emile Bellott looks at the changing biotech landscape in light of the global financial crisis and considers the likely implications for the global pharmaceutical/biotech industry  
view
download pdf
Mark B Hassenplug and Kai Gindner at Ernst & Young examine ways in which pharmaceutical companies can maintain standards in supply chain management  
view
download pdf
bullet
BioBusiness Development
Pharma and biotech companies often manage scientific assets and equipment on their own. Bob Moore at GE Healthcare discusses why and how outsourcing scientific asset services can help to improve effectiveness in the lab  
view
download pdf
Catherine D’Arcy at PA Consulting Group describes the requirement for greater efficiency and effectiveness in R&D operations and how working closely with a global pharmaceutical company has prompted a review of key functions  
view
download pdf
Richard Barratt at Barratt Legal examines the proliferation of outsourcing operational practices in the industry, and tells us how to get the best out of it  
view
download pdf
bullet
BioResearch and Innovation
Mats Hellström and Björn Frendéus at BioInvent International examine the developments that are occurring in monoclonal antibody drugs, and discuss their future in the fight against cancer  
view
download pdf
Birgit Jehn at QIAGEN GmbH gives an overview on HLA-Typing or pre-therapeutic testing in AIDS patients  
view
download pdf
bullet
Discovery Technology
David Bunton and Lee Rankin at Biopta Ltd and Alistair Corbett at Glasgow Caledonian University discuss opioid receptors as drug targets in gastrointestinal disorders  
view
download pdf
Graham Lappin at Xceleron argues that microdosing can provide important information about a drug’s behaviour before Phase I, thereby reducing the likelihood of costly failures at a later stage  
view
download pdf
bullet
BioDevelopment and Regulatory
Ulrich Braumann at Bruker BioSpin and Herbert Thiele at Bruker Daltonik analyse structure verification of small molecules using integrated MS spectrometry and NMR spectroscopy  
view
download pdf
Josep Prous at Thomson Reuters introduces biomarkers, identifying them as a crucial factor in the evolution of drug research and development  
view
download pdf
LABALisette Oversteegen at Datamonitor discusses combination product market trends in the respiratory drug sector  
view
download pdf
bullet
BioFormulation and Manufacturing
R Keith Williams at The Clinical Biotechnology Centre, Bristol Institute for Transfusion Sciences, NHS Blood and Transplant and Angela Osborne of eXmoor pharma concepts ltd discuss small-scale biomanufacturing for clinical trials, cell and gene therapies in the UK market  
view
download pdf
Kate Westwell and Gina Wenham at Eden Biodesign explain how implementing the quality cycle can deliver product value  
view
download pdf
bullet
BioRegional
Jacques Lhomel of Biocitech tells how one of Europe’s high-profile life science parks has boosted resources for life sciences R&D  
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July and October

News and Press Releases

WORLD’S FIRST PCM CARGO COVER

A British team of scientists at TLX Cargo Ltd have invented the worlds Cargo Cover/Thermal blanket that incorporates Phase Change Material (PCM) into it`s structure, solved the problem of hot lane temperature excursions on the tarmac.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

Industry Events

Clinical Trial Supply West Coast 2018

23-24 May 2018, Burlingame, CA

Clinical Trial Supply West Coast is returning for its 11th edition to share strategies for improving the efficiency of their clinical supply chain operations. The programme covers a broad range of topics including GMP compliance, transport management software, change control, machine learning, QP release and overcoming customs delays.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement